Managing Diabetes, Protecting Hearts — Welcome to the World of Empasmile 25
Introducing Empasmile 25: Advancing the Future of Diabetes Care We are proud to announce the launch of Empasmile 25, an advanced empagliflozin-based therapy developed to transform the management of type 2 diabetes mellitus. With a proven track record in glycemic control and cardiovascular protection, Empasmile 25 empowers healthcare providers and patients to achieve better outcomes…
